Quality-by-Design Optimization of Biotin-Coated Tetronic® 1107 Polymersomes for Carboplatin Delivery in Non-Small Cell Lung Cancer

ABSTRACT

Background:For driver-negative Non-Small Cell Lung Cancer (NSCLC), platinum-based chemotherapy remains standard; however, carboplatin efficacy is limited by poor tumour delivery and dose-limiting toxicity. In this study, we developed biotin-functionalised polymersomes encapsulating carboplatin to enhance carrier stability and enable selective tumour delivery via sodium-dependent multivitamin transporter uptake. Materials and Methods:A Box-Behnken design optimised Tetronic® 1107 polymersomes by modelling polymer concentration, temperature, and stirring time against particle size, zeta potential, and entrapment efficiency. The optimised formulation was characterised by dynamic light scattering (particle size distribution); atomic force and scanning electron microscopy (morphology); Fourier-transform infrared spectroscopy (interactions); differential scanning calorimetry (thermal behaviour); and powder X-ray diffraction (crystallinity). It was further evaluated for pH-dependent release and cytotoxicity in biotin-overexpressing A549 cells. Results:Box-Behnken optimisation yielded SMVT-targeted, biotin-functionalised Tetronic® 1107 polymersomes (PS = 246 nm; ZP = –26 mV; EE = 85%). FTIR, DSC, and XRD showed a preserved PEO/PPO matrix with amorphous carboplatin. AFM and SEM revealed a corrugated, biotin-rich corona. Release was sustained and pH-responsive, fitting the Weibull model (R²=0.93-0.97). In A549 cells, biotin-coated vesicles reduced the IC₅₀ 1.73-fold relative to free carboplatin (p< 0.05). Conclusion:Biotin-functionalised polymersomes improved carboplatin loading, stability, and tumour-targeted cytotoxicity, supporting their evaluation in vivofor NSCLC therapy.

KEYWORDS

• Biotin
• Polymersomes
• Carboplatin
• Nanocarriers
• Box-Behnken Optimisation

Showing references and in-text citations exactly as published.

• DOI10.5530/jyp.20250096Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 17, ISSUE 4Advances in Green Analytical Techniques for Impurity Profiling in PharmaceuticalsAnamika Dey, Nagarajan Janaki Sankarachari Krishnan, Shenthilnathan Sivakumar, Sarvesh Ravichandran, Mullaiadhavan Bharathi, Pavalan Krishnan · pp. 777–783Original ArtcileSame type: Article
• Article · VOLUME 17, ISSUE 4Pharma 4.0: Enhancing Process Robustness in Pharmaceutical Manufacturing through Industry 4.0 IntegrationRajesh Balam, Priyanka Mahesh, Kinjal Gandhi, Swathi Ganesha Poojary, Ajith Chandran, Anoop Narayanan Vadakkepushpakath · pp. 784–789Original ArtcileSame type: Article
• Article · VOLUME 17, ISSUE 4Formulation and Evaluation of Truptighna Mahakashaya Syrup: An Ayurvedic Intervention for Pediatric AppetizerAshwini Kumar Patil, Brugupati Pandey, Bharat Patil, Aboli Patil, Rupali Bawa · pp. 841–846Original ArtcileSame type: Article
• Article · VOLUME 17, ISSUE 4Strategic Alignment of Saudi Pharmacy Education and the Pharmaceutical Industry: A Document-Based SWOT and Matrix Evaluation under Vision 2030Farhan Alshammari · pp. 847–854Original ArtcileSame type: Article